Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.

This study aims to determine the predictive effect of ATG10 and IL6 genetic polymorphisms in safety and efficacy of sorafenib used for the treatment of Egyptian HCC patients. Moreover, this study will determine the association between genetic polymorphisms of ATG10 and IL6 with HCC severity.

  • 0 views
  • 20 Sep, 2023
  • 1 location
Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer

This phase II trial studies the best dose and side effects of sorafenib tosylate and nivolumab in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to nearby tissues or lymph nodes (locally advanced) or to other places in the body (metastatic). Sorafenib tosylate may …

  • 84 views
  • 13 Jun, 2022
  • 2 locations
Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for the Treatment of Liver Cancer After Progression on Prior PD-1 Inhibition

This phase II trial studies how well standard of care hypofractionated radiation therapy followed by durvalumab with or without tremelimumab works in treating patients with hepatocellular cancer (liver cancer) that has spread to other places in the body (advanced) and that is growing, spreading, or getting worse (progressing) after treatment …

  • 0 views
  • 25 Apr, 2022
  • 1 location
Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma (AP-LAPO)

Background: Hepatocellular carcinoma (HCC) is the sixth most common malignancy in the world. Major hepatectomy (resection of > 3 liver segments) is needed if tumor is close to major blood vessels within liver. Despite low mortality, open major hepatectomy (OMH) is associated with high tumor recurrence rate, and short survival. …

metastasis
ct scan
tumor cells
  • 0 views
  • 04 Sep, 2023
  • 1 location
Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma

It has been shown previously that gene expression profiling signature (a set of dysregulated genes) can be used for molecular classification, diagnosis, and prognosis of several types of cancers. In This study the hypothesise that resistant tumor may be due to genetic mutations and/or other alternative pathways that could be …

sorafenib
vascular invasion
prothrombin
international normalized ratio
coumadin
  • 16 views
  • 23 Jan, 2021
  • 1 location
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)

of patients at high risk of developing HCC with 6-monthly serum alpha-fetoprotein (AFP) and ultrasound imaging (US) has a sensitivity of approximately 63% for detecting early HCC. There is an urgent

  • 0 views
  • 04 Oct, 2022
  • 14 locations
Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants

Hepatic tumors in the perinatal period are associated with significant morbidity and mortality in affected patients. The conventional diagnostic tool, such as alpha-fetoprotein (AFP) shows

liver tumor
  • 0 views
  • 07 Jan, 2022
  • 1 location
Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma

-of-care surveillance of patients at high risk of developing HCC with 6-monthly serum alpha-fetoprotein (AFP) and ultrasound imaging (US) has a sensitivity of approximately 63% for detecting early HCC

TACE
cancer
  • 0 views
  • 04 Oct, 2022
  • 6 locations
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) (GALAD)

The objective of this observational study is to evaluate the clinical utility of the combined assay of 3 biomarkers: α-FP, α-FP-L3 and DCP (simultaneously measured by µTASWakoTM i30 automated in vitro diagnostic system) in high-risk subjects to develop this neoplasm. In particular, it aims to: Evaluate the clinical utility of …

  • 0 views
  • 03 Apr, 2023
Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform

This study aims to isolate CTCs in peripheral venous blood of liver cancer patients by inertial focusing principle-based microfluidic device, determine the relationship between the number of CTCs and patient prognosis and treatment response, detect mutation, copy number variation and mutation load in CTC cells and corresponding tissues using single-cell …

cancer
tumor cells
Accepts healthy volunteers
  • 0 views
  • 26 Mar, 2022
  • 1 location